Back to mobile site

More on SPRB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.5 Score)

Upcoming Events

- Earnings (3/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Spruce Biosciences (NQ:SPRB)
Delayed: 54.70 +2.34 (4.47%)
Prev. Close $52.36  
Open$52.05 
52 Wk High$ 
52 Wk Low$ 
Day High$55.95 
Day Low$52.00 
P/E N/A  
EPS$ 
Volume96,385 

Friends, Peers and Foes (?): SPRBD 6XY (more...)

Jun 22, 2026 08:00 AM Spruce Biosciences names medical affairs VP ahead of drug review
Jun 22, 2026 08:00 AM Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs
Jun 16, 2026 06:06 AM Guggenheim Starts Spruce Biosciences, Inc. (SPRB) at Buy
Jun 15, 2026 08:00 AM Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance
Jun 15, 2026 08:00 AM Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller
Jun 8, 2026 04:11 PM Jones Trading Starts Spruce Biosciences, Inc. (SPRB) at Buy
Jun 8, 2026 04:05 PM Spruce Biosciences presents long-term data for MPS IIIB treatment
Jun 8, 2026 04:05 PM Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
May 28, 2026 04:05 PM Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
May 27, 2026 04:05 PM Spruce Biosciences to Participate in Upcoming Conferences in June
View All Articles

Entities mentioned with SPRB

View All Entities